Completed NA INTERVENTIONAL 3-arm NCT01778686

Evaluation of [11C]Cimbi-36 as an Agonist PET Radioligand for Imaging of 5-HT2A Receptors

Sponsor: Gitte Moos Knudsen

Conditions Healthy

Interventions Acute tryptophan depletion Citalopram and Pindolol Placebo

Updated 7 times since 2017 Last updated: Jan 30, 2025 Started: Jan 31, 2013 Primary completion: Nov 30, 2013 Completion: Nov 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Healthy, this trial is completed. The trial is conducted by Gitte Moos Knudsen and has accumulated 7 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Mar 2025 — Present [monthly]

Completed NA
Nov 2024 — Mar 2025 [monthly]

Completed NA
Sep 2024 — Nov 2024 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jan 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Gitte Moos Knudsen

Data source: Rigshospitalet, Denmark

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Copenhagen, Denmark